116 related articles for article (PubMed ID: 1373482)
1. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III.
André C; Martin E; Cornu F; Hu WX; Wang XP; Galibert F
Oncogene; 1992 Apr; 7(4):685-91. PubMed ID: 1373482
[TBL] [Abstract][Full Text] [Related]
2. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene.
Giebel LB; Strunk KM; Holmes SA; Spritz RA
Oncogene; 1992 Nov; 7(11):2207-17. PubMed ID: 1279499
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
Shibuya M; Yamaguchi S; Yamane A; Ikeda T; Tojo A; Matsushime H; Sato M
Oncogene; 1990 Apr; 5(4):519-24. PubMed ID: 2158038
[TBL] [Abstract][Full Text] [Related]
4. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
[TBL] [Abstract][Full Text] [Related]
5. Cloning and structural analysis of the human c-kit gene.
Vandenbark GR; deCastro CM; Taylor H; Dew-Knight S; Kaufman RE
Oncogene; 1992 Jul; 7(7):1259-66. PubMed ID: 1377810
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes.
Andre C; Hampe A; Lachaume P; Martin E; Wang XP; Manus V; Hu WX; Galibert F
Genomics; 1997 Jan; 39(2):216-26. PubMed ID: 9027509
[TBL] [Abstract][Full Text] [Related]
7. Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse.
Rosnet O; Stephenson D; Mattei MG; Marchetto S; Shibuya M; Chapman VM; Birnbaum D
Oncogene; 1993 Jan; 8(1):173-9. PubMed ID: 8380915
[TBL] [Abstract][Full Text] [Related]
8. Structural organization of the murine c-kit proto-oncogene.
Gokkel E; Grossman Z; Ramot B; Yarden Y; Rechavi G; Givol D
Oncogene; 1992 Jul; 7(7):1423-9. PubMed ID: 1377813
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide sequence and structural organization of the human FMS proto-oncogene.
Hampe A; Shamoon BM; Gobet M; Sherr CJ; Galibert F
Oncogene Res; 1989; 4(1):9-17. PubMed ID: 2524025
[TBL] [Abstract][Full Text] [Related]
11. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
Coussens L; Van Beveren C; Smith D; Chen E; Mitchell RL; Isacke CM; Verma IM; Ullrich A
Nature; 1986 Mar 20-26; 320(6059):277-80. PubMed ID: 2421165
[TBL] [Abstract][Full Text] [Related]
12. The fms gene and the CSF-1 receptor.
Sherr CJ; Rettenmier CW
Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
[TBL] [Abstract][Full Text] [Related]
13. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.
Katoh M; Yazaki Y; Sugimura T; Terada M
Biochem Biophys Res Commun; 1993 May; 192(3):1189-97. PubMed ID: 7685162
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic receptors of class III receptor-type tyrosine kinases.
Rosnet O; Birnbaum D
Crit Rev Oncog; 1993; 4(6):595-613. PubMed ID: 7506935
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site.
Herbst R; Munemitsu S; Ullrich A
Oncogene; 1995 Jan; 10(2):369-79. PubMed ID: 7530827
[TBL] [Abstract][Full Text] [Related]
16. Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.
Kawagishi J; Kumabe T; Yoshimoto T; Yamamoto T
Genomics; 1995 Nov; 30(2):224-32. PubMed ID: 8586421
[TBL] [Abstract][Full Text] [Related]
17. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
Pajusola K; Aprelikova O; Armstrong E; Morris S; Alitalo K
Oncogene; 1993 Nov; 8(11):2931-7. PubMed ID: 7692369
[TBL] [Abstract][Full Text] [Related]
18. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.
Galland F; Karamysheva A; Pebusque MJ; Borg JP; Rottapel R; Dubreuil P; Rosnet O; Birnbaum D
Oncogene; 1993 May; 8(5):1233-40. PubMed ID: 8386825
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.
Trojani A; Ripamonti CB; Penco S; Beghini A; Nadali G; Di Bona E; Viola A; Castagnola C; Colapietro P; Grillo G; Pezzetti L; Ravelli E; Patrosso MC; Marocchi A; Cuneo A; Ferrara F; Lazzarino M; Pizzolo G; Cairoli R; Morra E
Anticancer Res; 2008; 28(5A):2745-51. PubMed ID: 19035305
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
